QUOTE AND NEWS
newratings.com  May 3  Comment 
WASHINGTON (dpa-AFX) - Verisk Analytics Inc. (VRSK) revealed a profit for its first quarter that rose compared to the same period last year. The company said its bottom line came in at $127.4 million, or $0.75 per share. This was higher than...
Mondo Visione  Apr 28  Comment 
NovitasFTCL acted as M&A advisor to the shareholders of Risk Intelligence Ireland on its sale to Verisk Analytics Inc.  This transaction, in the Insurance data / analytics sector, is our second sale this year of a European Fintech business to a...
Benzinga  Apr 26  Comment 
Verisk Analytics, Inc. (NASDAQ: VRSK), a data analytics provider to clients in insurance, natural resources, healthcare, financial services and other sectors, announced after Monday's market close it has entered into an agreement to sell its...
Insurance Journal  Apr 8  Comment 
Private equity firm Carlyle Group LP is in advanced talks to acquire the healthcare information technology division of U.S. data analytics company Verisk Analytics Inc., according to people familiar with the matter. Carlyle has so far prevailed in...
Reuters  Apr 7  Comment 
Private equity firm Carlyle Group LP is in advanced talks to acquire the healthcare information technology division of U.S. data analytics company Verisk Analytics Inc , according to...
Forbes  Feb 24  Comment 
In early trading on Wednesday, shares of Verisk Analytics (VRSK) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.4%. Year to date, Verisk Analytics has lost about 6.7% of its value.
newratings.com  Feb 23  Comment 
WASHINGTON (dpa-AFX) - Verisk Analytics Inc. (VRSK) released a profit for its fourth quarter that climbed compared to the same period last year. The company said its bottom line came in at $138.5 million, or $0.80 per share. This was higher than...
Forbes  Dec 18  Comment 
In early trading on Friday, shares of BioMarin Pharmaceutical (BMRN) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.0%. Year to date, BioMarin Pharmaceutical registers a 14.7% gain.





You may also be interested in articles related to Verisk Analytics, Inc. (VRSK):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki